1. Italy Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
Amplifon S.p.A.

Amplifon S.p.A.

AMFPF
Amplifon S.p.A.US flagOther OTC
11.21
USD
- -
- -
2.47BMarket Cap
Amplifon S.p.A.
AMFPF
(Other OTC)

Recent

price

11.21

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
3.64
3.87
3.92
3.81
4.1
4.74
5.17
5.78
6.2
7.81
6.72
8.66
9.45
10.01
10.69
10.89
10.77
Revenue per Share
0.16
0.2
0.2
0.06
0.21
0.21
0.29
0.46
0.46
0.49
0.45
0.7
0.8
0.69
0.65
0.42
0.56
Basic EPS, GAAP
0.29
0.19
0.3
0.25
0.34
0.36
0.37
0.44
0.47
1.03
1.48
1.55
1.53
1.2
1.35
1.35
1.33
Free Cash Flow per Basic Share
0.03
0.03
0.04
0.04
0.04
0.04
0.04
0.07
0.11
0.14
- -
0.22
0.26
0.29
0.29
0.3
- -
Dividend per Share
1.01
1.09
1.24
1.23
1.41
1.55
1.77
2.1
2.13
2.46
2.92
3.37
3.9
4.29
4.68
4.95
4.75
Book Value per Share
-1.76
-1.43
-1.23
-1.1
-1.04
-0.98
-1.09
-1.35
-4.21
-4
-3.76
-5.2
-5.05
-4.94
-5.43
-5.95
-5.85
Tangible Book Value per Share
195
214
216
217
217
218
219
219
220
222
224
225
224
226
225
220
224
Basic Weighted Avg Shares
708
827
847
827
891
1,034
1,133
1,266
1,362
1,732
1,503
1,948
2,119
2,260
2,409
2,396
2,412
Sales/Revenue/Turnover
9.22
11.85
11.66
8.53
10.24
11.07
11.86
11.91
11.57
10.4
11.1
12.52
12.61
11.09
10.51
8.55
9.77
Operating Margin (%)
32
44
47
48
47
52
54
63
72
193
202
222
240
268
303
315
316
Depreciation Expense
31
43
43
13
46
47
64
101
100
109
101
158
179
155
145
91
126
Net Income, GAAP
42.93
40.9
40.25
64.93
30.22
46.98
40.6
22.91
27.54
27.72
27.81
26.76
26.65
26.09
26.02
30.53
27.48
Effective Tax Rate (%)
4.32
5.16
5.1
1.55
5.22
4.53
5.61
7.94
7.37
6.27
6.72
8.1
8.42
6.86
6.03
3.81
5.21
Profit Margin (%)
8
14
-49
109
139
128
102
-234
-75
-236
170
-240
-463
-558
-445
-493
-435
Working Capital
- -
401
285
418
439
394
399
124
873
1,094
1,407
1,364
1,168
1,094
1,345
1,351
1,414
LT Debt
345
391
430
381
443
500
558
588
596
696
802
927
1,040
1,102
1,150
999
1,014
Total Equity
12.17
9.5
6.96
2.99
7.48
6.75
8.51
11.75
9.05
7.28
5.4
7.17
7.57
7.01
6.69
4.92
5.95
Return on Invested Capital (%)
31.58
13.25
8.47
3.25
8.46
7.95
9.66
13.86
9.84
7.87
5.93
7.77
8.46
7.73
7.13
4.66
6.09
Return on Capital (%)
26.65
19.93
17.3
4.81
16.22
14.51
17.48
23.67
21.64
21.44
16.85
22.39
21.89
16.83
14.37
8.52
12.22
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
382
395
418
LT Borrowings
957
964
1,041
LT Finance Leases
388
384
373
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
225
225
222
Market Capitalization
5,669
4,587
4,533

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
725
710
680
Cash, Cash Equivalents & STI
289
261
243
Accounts Receivable, Net
227
228
220
Inventories
93
99
94
Total Current Liabilities
1,170
1,142
1,115
Payables & Accruals
- -
- -
- -
ST Debt
382
395
418
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.52%
4.99%
-13.19%
Free Cash Flow
18.87%
-1.51%
-2.75%
Net Income, GAAP
10.78%
2.56%
-37.17%
Sales/Revenue/Turnover
9.39%
10.21%
-0.56%
Total Cash Common Dividend
- -
17.93%
-0.44%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
573
604
573
659
2,409
2025
588
593
649
- -
2,396
2026
580
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.15
0.23
- -
0.18
0.65
2025
0.15
0.16
0.08
- -
0.42
2026
0.05
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.29
2025
- -
- -
- -
- -
0.3
2026
- -
- -
- -
- -
- -
Similar Companies
Winnergy Medical Public Company Limited (WINMED.BK)
Nexus Surgical and Medicare Limited (NEXUSSURGL.BO)
Cardinal Health, Inc. (0HTG.L)
China National Accord Medicines Corporation Ltd. (000028.SZ)
Healthlead Public Company Limited (HL.BK)
MediPal Holdings Corporation (7459.T)
Business
Amplifon S.p.A. is a global leader in hearing care retail, headquartered in Milan, Italy, and founded in 1950. The company specializes in the distribution, customization, and fitting of hearing solutions designed to help individuals rediscover the emotions of sound. Its core product portfolio includes a wide range of hearing aids and auditory prostheses under brands such as Amplifon, Miracle-Ear, Beter Horen, and Sonus, complemented by advanced hearing aid technologies like Ampli-Easy, Ampli-Mini, Ampli-Connect, and Ampli-Energy. These products feature innovative functions such as Bluetooth connectivity, noise reduction, and rechargeable batteries, aimed at enhancing user experience. Amplifon also provides comprehensive services including hearing diagnosis, fitting, maintenance, and personalized customer care. The company operates through an extensive global network of approximately 10,000 points of sale including owned stores, franchise outlets, and shop-in-shops, covering Europe, the Middle East, Africa (EMEA), the Americas, and Asia-Pacific regions. Its geographic presence spans major markets such as Italy, France, Germany, the United States, Canada, Australia, China, and several Latin American countries, reflecting a diversified and robust international footprint. Recent strategic initiatives include the acceleration of the "Fit4Growth" program aimed at improving operational efficiency and profitability by restructuring its retail network, including the selective closure of around 100 underperforming clinics as of late 2025. Amplifon has pursued growth through acquisitions primarily in France, Germany, Poland, the United States, Canada, and China, reinforcing its market position in these key territories. In 2024, the company reported revenue growth supported by these acquisitions and organic expansion, with a focus on maximizing performance in the US market through its Miracle-Ear and Amplifon Hearing Healthcare businesses. Amplifon also emphasizes technological innovation and digital transformation to strengthen its competitive edge and enhance customer engagement. Amplifon is positioned within the hearing care and medical equipment industry, targeting hearing-impaired individuals requiring customized auditory solutions and services. The company’s advanced product offerings, combined with a global retail presence and ongoing strategic initiatives, affirm its leadership role and commitment to sustained growth in the hearing care market. This comprehensive profile reflects Amplifon's main products and services alongside its latest significant operational and strategic changes.

Company News

APIChatGPT

  • zacks.com

    Is Amplifon (AMFPF) Stock Undervalued Right Now?

  • seekingalpha.com

    Amplifon S.p.A. (AMFPY) Q1 2026 Earnings Call Transcript

  • reuters.com

    EssilorLuxottica considered investing in Amplifon in the past, CEO says

  • defenseworld.net

    Amplifon (OTCMKTS:AMFPF) versus First Choice Healthcare Solutions (OTCMKTS:FCHS) Critical Contrast

  • seekingalpha.com

    Amplifon S.p.A. (AMFPF) Q4 2025 Earnings Call Transcript

  • defenseworld.net

    Sonic Healthcare (OTCMKTS:SKHHY) and Amplifon (OTCMKTS:AMFPF) Critical Survey

  • defenseworld.net

    Amplifon (OTCMKTS:AMFPF) vs. Eurofins Scient (OTCMKTS:ERFSF) Head to Head Analysis

  • defenseworld.net

    Amplifon (OTCMKTS:AMFPF) Stock Price Up 12.7% – Here’s What Happened

  • seekingalpha.com

    Oakmark International Small Cap Strategy Q3 2025 Top Contributors And Detractors

  • seekingalpha.com

    Amplifon S.p.A. (AMFPF) Q3 2025 Earnings Call Transcript

  • reuters.com

    SHORT TAKE Amplifon posts Q3 profit fall, confirms 2025 guidance

  • seekingalpha.com

    Significant Research Activity Led To Six New Positions

  • seekingalpha.com

    Stock Picks From Seeking Alpha's August 2025 New Analysts

  • seekingalpha.com

    Amplifon: iPhone Moment Or Contrarian Opportunity Of The Year?

  • seekingalpha.com

    Amplifon: The Hearing Care Giant Is Ready To Restart

  • reuters.com

    Italy's Amplifon posts 2024 margin below guidance, shares drop 12%

  • seekingalpha.com

    Amplifon: A Global Leader In Hearing Care Retailing, Initiate With A 'Buy'

  • businesswire.com

    Amplifon Hearing Health Care Achieves HITRUST r2 Certification

  • reuters.com

    Italy's Amplifon trims margin forecast after lower Q3 profit

  • businesswire.com

    Amplifon Named One of the 200 “America's Most Loved Workplaces” by Newsweek